Functional vascular endothelial growth factor gene polymorphisms and diabetes: Effect on coronary collaterals in patients with significant coronary artery disease

Clinica Chimica Acta

Volumn 411, Issue 21-22, 2010, Pages 1688-1693

  Lin, Tsung Hsien ^a,b   Wang, Chiao Ling ^c   Su, Ho Ming ^a,b   Hsu, Po Chao ^a   Juo, Suh Hang Hank ^c   Voon, Wen Chol ^a,b   Shin, Shyi Jang ^a,c   Lai, Wen Ter ^a,b   Sheu, Sheng Hsiung ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Collateral; Coronary; Diabetes; Gene; Polymorphism; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CHINESE; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77956474489     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.07.002     Document Type: Article

References (37)

1. Cohen M., Rentrop K.P. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: A prospective study. Circulation Sep 1986, 74(3):469-476.
2. Meier P., Gloekler S., Zbinden R., et al. Beneficial effect of recruitable collaterals: A 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation Aug 28 2007, 116(9):975-983.
3. Regieli J.J., Jukema J.W., Nathoe H.M., et al. Coronary collaterals improve prognosis in patients with ischemic heart disease. Int J Cardiol Feb 20 2009, 132(2):257-262.
4. Lin T.H., Yen H.W., Voon W.C., et al. Vascular endothelial growth factor in coronary sinus: Evidence for its association with coronary collaterals. Scand Cardiovasc J Dec 2005, 39(6):353-357.
5. Henry T.D., Annex B.H., McKendall G.R., et al. The VIVA trial: Vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation Mar 18 2003, 107(10):1359-1365.
6. Hendel R.C., Henry T.D., Rocha-Singh K., et al. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: Evidence for a dose-dependent effect. Circulation Jan 18 2000, 101(2):118-121.
7. Vincenti V., Cassano C., Rocchi M., Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation Apr 15 1996, 93(8):1493-1495.
8. Watson C.J., Webb N.J., Bottomley M.J., Brenchley P.E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine Aug 2000, 12(8):1232-1235.
9. Young H.S., Summers A.M., Read I.R., et al. Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. J Invest Dermatol Feb 2006, 126(2):453-459.
10. Szeto C.C., Chow K.M., Poon P., Szeto C.Y., Wong T.Y., Li P.K. Genetic polymorphism of VEGF: Impact on longitudinal change of peritoneal transport and survival of peritoneal dialysis patients. Kidney Int May 2004, 65(5):1947-1955.
11. Rentrop K.P., Cohen M., Blanke H., Phillips R.A. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol Mar 1985, 5(3):587-592.
12. Pepper M.S. Manipulating angiogenesis: From basic science to the bedside. Arterioscler Thromb Vasc Biol 1997, 17:605-619.
13. Henry T.D. Therapeutic angiogenesis. BMJ 1999, 318:1536-1539.
14. Losordo D.W., Vale P.R., Symes J.F., et al. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation Dec 22-29 1998, 98(25):2800-2804.
15. Vale P.R., Losordo D.W., Milliken C.E., et al. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation Aug 29 2000, 102(9):965-974.
16. Sherman J.A., Hall A., Malenka D.J., De Muinck E.D., Simons M. Humoral and cellular factors responsible for coronary collateral formation. Am J Cardiol Nov 1 2006, 98(9):1194-1197.
17. Conway E.M., Collen D., Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res Feb 16 2001, 49(3):507-521.
18. Semenza G.L. Surviving ischemia: Adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest Oct 2000, 106(7):809-812.
19. Resar J.R., Roguin A., Voner J., et al. Hypoxia-inducible factor 1alpha polymorphism and coronary collaterals in patients with ischemic heart disease. Chest Aug 2005, 128(2):787-791.
20. Sung K.C., Kim K.S., Lee S. Hypoxic regulation of VEGF, HIF-1(alpha) in coronary collaterals development. Korean J Intern Med Dec 2005, 20(4):295-302.
21. Smith R.S., Lin K.F., Agata J., Chao L., Chao J. Human endothelial nitric oxide synthase gene delivery promotes angiogenesis in a rat model of hindlimb ischemia. Arterioscler Thromb Vasc Biol Aug 1 2002, 22(8):1279-1285.
22. Prior B.M., Lloyd P.G., Ren J., et al. Arteriogenesis: Role of nitric oxide. Endothelium 2003, 10(4-5):207-216.
23. van der Zee R., Murohara T., Luo Z., et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release form quiescent rabbit and human vascular endothelium. Circulation 1997, 95:1030-1037.
24. Papapetropoulos A., Garcia-Cardena G., Madri J.A., Sessa W.C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997, 100:3131-3139.
25. Ziche M., Morbidelli L., Choudhuri R., et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest Jun 1 1997, 99(11):2625-2634.
26. Gulec S., Karabulut H., Ozdemir A.O., et al. Glu298Asp polymorphism of the eNOS gene is associated with coronary collateral development. Atherosclerosis Jun 2008, 198(2):354-359.
27. Lamblin N., Cuilleret F.J., Helbecque N., et al. A common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions. BMC Cardiovasc Disord Sep 15 2005, 5:27.
28. Nakamura S., Iwasaki N., Funatsu H., Kitano S., Iwamoto Y. Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2009, Jan;247(1):21-6.
29. Abaci A., Oǧuzhan A., Kahraman S., et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation May 4 1999, 99(17):2239-2242.
30. Waltenberger J., Lange J., Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytesis attenuated in patients with diabetes mellitus. A potential predictor for the individual capacity to develop collaterals. Circulation 2000, 102:185-190.
31. Waltenberger J. Impaired collateral vessel development in diabetes: Potential cellular mechanisms and therapeutic implications. Cardiovasc Res 2001, 49:554-560.
32. Altavilla D., Saitta A., Cucinotta D., et al. Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes 2001, 50:667-674.
33. Ray D., Mishra M., Ralph S., Read I., Davies R., Brenchley P. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes Mar 2004, 53(3):861-864.
34. Sasayama S., Fujita M. Recent insights into coronary collateral circulation. Circulation Mar 1992, 85(3):1197-1204.
35. Charney R., Cohen M. The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size. Am Heart J Oct 1993, 126(4):937-945.
36. Waldecker B., Waas W., Haberbosch W., Voss R., Wiecha J., Tillmanns H. Prevalence and significance of coronary collateral circulation in patients with acute myocardial infarct. Z Kardiol Mar 2002, 91(3):243-248.
37. Antoniucci D., Valenti R., Moschi G., et al. Relation between preintervention angiographic evidence of coronary collateral circulation and clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. Am J Cardiol Jan 15 2002, 89(2):121-125.